Literature DB >> 20095854

Novel breast cancer risk alleles and interaction with ionizing radiation among U.S. radiologic technologists.

Parveen Bhatti1, Michele M Doody, Preetha Rajaraman, Bruce H Alexander, Meredith Yeager, Amy Hutchinson, Laurie Burdette, Gilles Thomas, David J Hunter, Steven L Simon, Robert M Weinstock, Marvin Rosenstein, Marilyn Stovall, Dale L Preston, Martha S Linet, Robert N Hoover, Stephen J Chanock, Alice J Sigurdson.   

Abstract

As genome-wide association studies of breast cancer are replicating findings and refinement studies are narrowing the signal location, additional efforts are necessary to elucidate the underlying functional relationships. One approach is to evaluate variation in risk by genotype based on known breast carcinogens, such as ionizing radiation. Given the public health concerns associated with recent increases in medical radiation exposure, this approach may also identify potentially susceptible subpopulations. We examined interaction between 27 newly identified breast cancer risk alleles (identified within the NCI Cancer Genetic Markers of Susceptibility and the Breast Cancer Association Consortium genome-wide association studies) and occupational and medical diagnostic radiation exposure among 859 cases and 1083 controls nested within the United States Radiologic Technologists cohort. We did not find significant variation in the radiation-related breast cancer risk for the variant in RAD51L1 (rs10483813) on 14q24.1 as we had hypothesized. In exploratory analyses, we found that the radiation-associated breast cancer risk varied significantly by linked markers in 5p12 (rs930395, rs10941679, rs2067980 and rs4415084) in the mitochondrial ribosomal protein S30 (MRPS30) gene (P(interaction) = 0.04). Chance, however, may explain these findings, and as such, these results need to be confirmed in other populations with low to moderate levels of radiation exposure. Even though a complete understanding of the way(s) in which these variants may increase breast cancer risk remains elusive, this approach may yield clues for further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20095854      PMCID: PMC2922870          DOI: 10.1667/RR1985.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  25 in total

1.  Breast cancer incidence in U.S. radiologic technologists.

Authors:  Michele Morin Doody; D Michal Freedman; Bruce H Alexander; Michael Hauptmann; Jeremy S Miller; R Sowmya Rao; Kiyohiko Mabuchi; Elaine Ron; Alice J Sigurdson; Martha S Linet
Journal:  Cancer       Date:  2006-06-15       Impact factor: 6.860

Review 2.  Radiation-induced signal transduction and stress response.

Authors:  A Haimovitz-Friedman
Journal:  Radiat Res       Date:  1998-11       Impact factor: 2.841

3.  Characterization of radiation-induced apoptosis in rodent cell lines.

Authors:  M Guo; C Chen; C Vidair; S Marino; W C Dewey; C C Ling
Journal:  Radiat Res       Date:  1997-03       Impact factor: 2.841

4.  Cloning, expression, and mapping of PDCD9, the human homolog of Gallus gallus pro-apoptotic protein p52.

Authors:  L Carim; L Sumoy; M Nadal; X Estivill; M Escarceller
Journal:  Cytogenet Cell Genet       Date:  1999

5.  Diagnostic x-ray procedures and risk of leukemia, lymphoma, and multiple myeloma.

Authors:  J D Boice; M M Morin; A G Glass; G D Friedman; M Stovall; R N Hoover; J F Fraumeni
Journal:  JAMA       Date:  1991-03-13       Impact factor: 56.272

Review 6.  Temporal distributions of risk for radiation-induced cancers.

Authors:  C E Land
Journal:  J Chronic Dis       Date:  1987

7.  A novel 52 kDa protein induces apoptosis and concurrently activates c-Jun N-terminal kinase 1 (JNK1) in mouse C3H10T1/2 fibroblasts.

Authors:  L Sun; Y Liu; M Frémont; S Schwarz; M Siegmann; R Matthies; J P Jost
Journal:  Gene       Date:  1998-02-27       Impact factor: 3.688

8.  Cancer incidence in the US radiologic technologists health study, 1983-1998.

Authors:  Alice J Sigurdson; Michele Morin Doody; R Sowmya Rao; D Michal Freedman; Bruce H Alexander; Michael Hauptmann; Aparna K Mohan; Shinji Yoshinaga; Deirdre A Hill; Robert Tarone; Kiyohiko Mabuchi; Elaine Ron; Martha S Linet
Journal:  Cancer       Date:  2003-06-15       Impact factor: 6.860

9.  A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

Authors:  Gilles Thomas; Kevin B Jacobs; Peter Kraft; Meredith Yeager; Sholom Wacholder; David G Cox; Susan E Hankinson; Amy Hutchinson; Zhaoming Wang; Kai Yu; Nilanjan Chatterjee; Montserrat Garcia-Closas; Jesus Gonzalez-Bosquet; Ludmila Prokunina-Olsson; Nick Orr; Walter C Willett; Graham A Colditz; Regina G Ziegler; Christine D Berg; Saundra S Buys; Catherine A McCarty; Heather Spencer Feigelson; Eugenia E Calle; Michael J Thun; Ryan Diver; Ross Prentice; Rebecca Jackson; Charles Kooperberg; Rowan Chlebowski; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Alice Sigurdson; Michele Doody; Parveen Bhatti; Bruce H Alexander; Julie Buring; I-Min Lee; Lars J Vatten; Kristian Hveem; Merethe Kumle; Richard B Hayes; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert N Hoover; Stephen J Chanock; David J Hunter
Journal:  Nat Genet       Date:  2009-03-29       Impact factor: 38.330

Review 10.  Radiation and breast cancer: a review of current evidence.

Authors:  Cécile M Ronckers; Christine A Erdmann; Charles E Land
Journal:  Breast Cancer Res       Date:  2004-11-23       Impact factor: 6.466

View more
  18 in total

Review 1.  Cancer risks associated with external radiation from diagnostic imaging procedures.

Authors:  Martha S Linet; Thomas L Slovis; Donald L Miller; Ruth Kleinerman; Choonsik Lee; Preetha Rajaraman; Amy Berrington de Gonzalez
Journal:  CA Cancer J Clin       Date:  2012-02-03       Impact factor: 508.702

Review 2.  A New Era of Low-Dose Radiation Epidemiology.

Authors:  Cari M Kitahara; Martha S Linet; Preetha Rajaraman; Estelle Ntowe; Amy Berrington de González
Journal:  Curr Environ Health Rep       Date:  2015-09

Review 3.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

4.  Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.

Authors:  Amit D Joshi; Sara Lindström; Anika Hüsing; Myrto Barrdahl; Tyler J VanderWeele; Daniele Campa; Federico Canzian; Mia M Gaudet; Jonine D Figueroa; Laura Baglietto; Christine D Berg; Julie E Buring; Stephen J Chanock; María-Dolores Chirlaque; W Ryan Diver; Laure Dossus; Graham G Giles; Christopher A Haiman; Susan E Hankinson; Brian E Henderson; Robert N Hoover; David J Hunter; Claudine Isaacs; Rudolf Kaaks; Laurence N Kolonel; Vittorio Krogh; Loic Le Marchand; I-Min Lee; Eiliv Lund; Catherine A McCarty; Kim Overvad; Petra H Peeters; Elio Riboli; Fredrick Schumacher; Gianluca Severi; Daniel O Stram; Malin Sund; Michael J Thun; Ruth C Travis; Dimitrios Trichopoulos; Walter C Willett; Shumin Zhang; Regina G Ziegler; Peter Kraft
Journal:  Am J Epidemiol       Date:  2014-09-25       Impact factor: 4.897

5.  Integrative analysis of multiple cancer prognosis studies with gene expression measurements.

Authors:  Shuangge Ma; Jian Huang; Fengrong Wei; Yang Xie; Kuangnan Fang
Journal:  Stat Med       Date:  2011-08-25       Impact factor: 2.373

6.  The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors.

Authors:  David A Quigley; Elisa Fiorito; Silje Nord; Peter Van Loo; Grethe Grenaker Alnæs; Thomas Fleischer; Jorg Tost; Hans Kristian Moen Vollan; Trine Tramm; Jens Overgaard; Ida R Bukholm; Antoni Hurtado; Allan Balmain; Anne-Lise Børresen-Dale; Vessela Kristensen
Journal:  Mol Oncol       Date:  2013-12-03       Impact factor: 6.603

7.  Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.

Authors:  Daniele Campa; Rudolf Kaaks; Loïc Le Marchand; Christopher A Haiman; Ruth C Travis; Christine D Berg; Julie E Buring; Stephen J Chanock; W Ryan Diver; Lucie Dostal; Agnes Fournier; Susan E Hankinson; Brian E Henderson; Robert N Hoover; Claudine Isaacs; Mattias Johansson; Laurence N Kolonel; Peter Kraft; I-Min Lee; Catherine A McCarty; Kim Overvad; Salvatore Panico; Petra H M Peeters; Elio Riboli; Maria José Sanchez; Fredrick R Schumacher; Guri Skeie; Daniel O Stram; Michael J Thun; Dimitrios Trichopoulos; Shumin Zhang; Regina G Ziegler; David J Hunter; Sara Lindström; Federico Canzian
Journal:  J Natl Cancer Inst       Date:  2011-07-26       Impact factor: 13.506

8.  Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach.

Authors:  Katie M O'Brien; Stephen R Cole; Charles Poole; Jeannette T Bensen; Amy H Herring; Lawrence S Engel; Robert C Millikan
Journal:  Am J Epidemiol       Date:  2013-11-10       Impact factor: 4.897

9.  A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer.

Authors:  Peter M Scarbrough; Rachel Palmieri Weber; Edwin S Iversen; Yonathan Brhane; Christopher I Amos; Peter Kraft; Rayjean J Hung; Thomas A Sellers; John S Witte; Paul Pharoah; Brian E Henderson; Stephen B Gruber; David J Hunter; Judy E Garber; Amit D Joshi; Kevin McDonnell; Doug F Easton; Ros Eeles; Zsofia Kote-Jarai; Kenneth Muir; Jennifer A Doherty; Joellen M Schildkraut
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-04       Impact factor: 4.254

10.  Association between 1p11-rs11249433 polymorphism and breast cancer susceptibility: evidence from 15 case-control studies.

Authors:  Sheng Wu; Jungang Cai; Hong Wang; Hongwei Zhang; Weige Yang
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.